Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line

Toxicology

Volumn 223, Issue 1-2, 2006, Pages 136-143

  Huan, Steven Kuan Hua ^a   Lee, Hao Hsien ^a   Liu, Der Zen ^b   Wu, Chien Chih ^c   Wang, Ching Chiung ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cantharidin; Chinese blister beetle (Mylabris phalerata Pallas); Cyclooxygenase 2; Cystitis; Cytotoxicity; Inflammation

Indexed keywords

CANTHARIDIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROSTAGLANDIN E2;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; BLOTTING, WESTERN; CANTHARIDIN; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; MEDICINE, CHINESE TRADITIONAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

MYLABRIS;

EID: 33646751454     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.012     Document Type: Article

References (27)

1. Altorki N.K., Port J.L., Zhang F., Golijanin D., Thaler H.T., Duffield-Lillico A.J., Subbaramaiah K., and Dannenberg A.J. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin. Cancer Res. 11 (2005) 4191-4197
2. Bruggisser R., Daeniken K.V., Jundt G., Schaffner W., and Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med. 68 (2002) 445-448
3. Efferth T., Rauh R., Kahl S., Tomicic M., Bochzelt H., Tome M.E., Briehl M.M., Bauer R., and Kaina B. Molecular modes of action of cantharidin in tumor cells. Biochem. Pharmacol. 69 (2005) 811-888
4. Eguchi Y., Srinivasan A., Tomaselli K.J., Shimizu S., and Tsujimoto Y. ATP-dependent steps in apoptotic signal transduction. Cancer Res. 59 (1999) 2174-2181
5. Graziano M.J., et al. Partial characterization of specific cantharidin binding sites in mouse tissue. Mol. Pharmacol. 33 (1988) 706-712
6. Hartwell L.H., and Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 246 (1989) 629-634
7. Hoang, B., Zhu, L., Shi, Y., Frost, P., Yan, H., Sharma, S., Goodglick, L., Dubinett, S., Lichtenstein, A., 2006. Oncogenic ras mutations in myeloma cells selectively induce COX-2 expression which participates in enhanced to fibronectin and chemoresistance, Blood 23, in press.
8. Huh J.E., Kang K.S., Chae C., Kim H.M., Ahn K.S., and Kim S.H. Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem. Pharmacol. 67 (2004) 1811-1818
9. Hundt H.K.L., Steyn J.M., and Wagner L. Post-mortem serum concentration of cantharidin in a fatal case of cantharides poisoning. Hum. Exp. Toxicol. 9 (1990) 35-40
10. Jackman M., Lindon C., Nigg E.A., and Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell. Biol. 5 (2003) 143-148
11. Karras D.J., Farrell S.E., Harrigan R.A., Henretig F.M., and Gealt L. Poisoning from "Spanish fly" (cantharidin). Am. J. Emerg. Med. 14 (1996) 478-483
12. Kotha S., Janice C.H., Larry N., and Andrew J.D. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. J. Biol. Chem. 275 (2000) 14838-14845
13. Li C., Teng R.H., Tsai Y.C., Ke H.S., Huang J.Y., Chen C.C., Kao Y.L., Kuo C.C., Bell W.R., and Shieh B. H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells. Br. J. Cancer 17 (2005) 80-88
14. 3H] endothelial thioanhydride binding site. Biochem. Pharmacol. 46 (1993) 1435-1443
15. Malumbres M., and Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1 (2001) 222-231
16. Nickolls L.C., and Teare D. Poisoning by cantharidin. Br. Med. J. 11 (1954) 1384-1386
17. Oak W.W., Ditunno J.F., Magnani T., Levy H.A., and Mills L.C. Cantharidin poisoning. Arch. Intern. Med. 105 (1960) 574-582
18. Rajesh D., Schell K., and Verma A.K. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol. Pharmacol. 56 (1999) 515-525
19. Ruvolo P.P., Deng X.M., Ito T., Carr B.K., and May W.S. Ceramide induces Bcl-2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274 (1999) 20296
20. Sakoff J.A., Ackland S.P., Baldwin M.L., Keane M.A., and McCluskey A. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Invest. New Drugs 20 (2002) 1-11
21. Sakoff J.A., Howitt I.J., Ackland S.P., and McCluskey A. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition. Cancer Chemother. Pharmacol. 53 (2004) 225-232
22. Taylor B.K., Stoops T.D., and Everett A.D. Protein phosphatase inhibitors arrest cell cycle and reduce branching morphogenesis in fetal rat lung cultures. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L1062-L1070
23. Walter W.G. Antitumor imide derivatives of 7-oxabicyclo[2.2.1] heptane-2,3-dimethyl-2,3-dicarboxylic acid. J. Pharm. Sci. 78 (1989) 66-67
24. Wang G.-S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol. 26 (1989) 147-162
25. Wang C.-C., Wu C.-H., Hsieh K.-J., Yen K.-Y., and Yang L.-L. Cytotoxic effects of cantharidin on growth of normal and carcinoma cells. Toxicology 147 (2000) 77-87
26. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 701-704
27. Zhang Y.H., and Chen X. Effect of disodium cantharidate and injectable herbal medicine on energy and cycle nucleotide metabolism in hepatoma 22 cells and liver tissues of tumorbearing mice. Chin. J. Integ. Trad. West. Med. 5 (1985) 686-690